Andrew Tsatsanis - Concepedia

Concepedia

Author

Andrew Tsatsanis

The University of Melbourne

Also Known As

A Tsatsanis, Andrew Tsatsanis, Tsatsanis, Andrew

30

Publications

1.9K

Citations

13

H-Index

39

Concepts

All Affiliations

The University of Melbourne University of Leeds Florey Institute of Neuroscience and Mental Health Mental Health Research Institute University of Cambridge

AT

About

Andrew Tsatsanis is an author at The University of Melbourne specializing in medicine, neurology, and neurodegenerative diseases.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	1.5K
2	Biochemistry	6	6	985
3	Social Sciences	4	4	705
4	Natural Sciences	2	2	80
5	Chemistry	1	1	40

Andrew Tsatsanis

×

13

Publications

1.9K

Citations

13

H-Index

	Year	Citations
Iron-Export Ferroxidase Activity of β-Amyloid Precursor Protein Is Inhibited by Zinc in Alzheimer's Disease James A. Duce, Andrew Tsatsanis, Michael A. Cater, Cell Neurodegenerative DiseasesAlzheimer's DiseaseBiochemistryIron MetabolismMetalloprotein	2010	660
PBT2 Rapidly Improves Cognition in Alzheimer's Disease: Additional Phase II Analyses Noel G. Faux, Craig Ritchie, Adam P. Gunn, Journal of Alzheimer s Disease Neurodegenerative DiseasesNeuropsychologyAlzheimer's DiseasePbt2 50Medicine	2010	388
ID1 and ID3 Regulate the Self-Renewal Capacity of Human Colon Cancer-Initiating Cells through p21 Catherine O′Brien, Antonija Kreso, Paul M. Ryan, Cancer Cell	2012	226
β-Amyloid Precursor Protein Does Not Possess Ferroxidase Activity but Does Stabilize the Cell Surface Ferrous Iron Exporter Ferroportin Bruce X. Wong, Andrew Tsatsanis, Linh Q Lim, PLoS ONE Iron MetabolismMolecular BiologyAmyloid Precursor ProteinRedox BiologySocial Sciences	2014	153
Zinc and copper modulate Alzheimer Aβ levels in human cerebrospinal fluid Lenore J. Launer, Paul A. Adlard, Robert A. Cherny, Neurobiology of Aging Neurodegenerative DiseasesAlzheimer's DiseaseMolecular NeuroscienceMedicineHuman Cerebrospinal Fluid	2007	150
SLC30A3 Responds to Glucose- and Zinc Variations in ß-Cells and Is Critical for Insulin Production and In Vivo Glucose-Metabolism During ß-Cell Stress Niels Jessen, Andreas Brønden Petersen, Agnete Larsen, PLoS ONE	2009	87
Amyloidogenic processing of Alzheimer’s disease β-amyloid precursor protein induces cellular iron retention Andrew Tsatsanis, Bruce X. Wong, Adam P. Gunn, Molecular Psychiatry Neurodegenerative DiseasesAlzheimer's DiseaseBiochemistryAmyloidogenic ProcessingDegenerative Pathology	2020	78
The acute phase protein lactoferrin is a key feature of Alzheimer’s disease and predictor of Aβ burden through induction of APP amyloidogenic processing Andrew Tsatsanis, Andrew N. McCorkindale, Bruce X. Wong, Molecular Psychiatry	2021	49
Post Translational Modulation of β-Amyloid Precursor Protein Trafficking to the Cell Surface Alters Neuronal Iron Homeostasis Andrew Tsatsanis, S. Dickens, Jessica C. F. Kwok, Neurochemical Research	2019	41
Protection from neurodegeneration in the 6-hydroxydopamine (6-OHDA) model of Parkinson's with novel 1-hydroxypyridin-2-one metal chelators David G. Workman, Andrew Tsatsanis, Frank W. Lewis, Metallomics Bioorganic ChemistryBrain Iron AccumulationChemistryRedox BiologyOxidative Stress	2015	40

Page 1